Skip to main content
Clinical Trials/CTRI/2023/09/057299
CTRI/2023/09/057299
Not yet recruiting
Phase 1

Comparative study of the duration of post operative analgesia with different doses of intrathecal Dexmedetomidine as adjuvant to 0.5% Hyperbaric Bupivacaine & with Bupivacaine alone in Total Abdominal Hysterectomy surgeries. - randomized double blind study. - NA

Jubilee Mission Medical College and Research Institute0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: N852- Hypertrophy of uterusHealth Condition 2: O- Medical and Surgical
Sponsor
Jubilee Mission Medical College and Research Institute
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Jubilee Mission Medical College and Research Institute

Eligibility Criteria

Inclusion Criteria

  • ASA I \& ASA II
  • PATIENTS SCHEDULED TOTAL ABDOMINAL HYSTERECTOMY

Exclusion Criteria

  • Patients with baseline Heart rate \< 60 or on Beta blockers / Alpha agonist.
  • Patient refusal for study participation .
  • Local infection at injection site.
  • Presence of any coagulopathies or bleeding disorders or patients on anticoagulation.
  • PRESENCE OF NEUROLOGICAL DEFICITS, PERIPHERAL NEUROPATHIES, MYOPATHIES, OR CHRONIC PAIN IN THE OPERATING LIMB.
  • PATIENTS WITH KNOWN ALLERGY TO LOCAL ANAESTHETICS OR TO ANY STUDY DRUGS TO BE USED.
  • HEMODYNAMICALLY COMPROMISED PATIENTS
  • ALCOHOLIC/ PSYCHIATRIC/UNCOOPERATIVE PATIENTS
  • PATIENTS WITH HEPATIC / RENAL OR CARDIOPULMONARY DISORDERS.
  • PATIENTS LESS THAN 5 FEET HEIGHT.

Outcomes

Primary Outcomes

Not specified

Similar Trials